Cargando…

Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients

BACKGROUND: Diabetic retinopathy (DR) is an important complication of diabetes and is considered one of the main causes of blindness in moderate-income and highly-developed countries. As it is a major socioeconomic problem, defining all mechanisms that may lead to DR development is of great importan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mrugacz, Małgorzata, Bryl, Anna, Bossowski, Artur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333582/
https://www.ncbi.nlm.nih.gov/pubmed/27212050
http://dx.doi.org/10.2174/1570159X14666160523144245
_version_ 1782511736789663744
author Mrugacz, Małgorzata
Bryl, Anna
Bossowski, Artur
author_facet Mrugacz, Małgorzata
Bryl, Anna
Bossowski, Artur
author_sort Mrugacz, Małgorzata
collection PubMed
description BACKGROUND: Diabetic retinopathy (DR) is an important complication of diabetes and is considered one of the main causes of blindness in moderate-income and highly-developed countries. As it is a major socioeconomic problem, defining all mechanisms that may lead to DR development is of great importance. In the 21st century diabetic lesions occurring in the retina are well known. However what kind of retinal neuronal damage occurs in the course of diabetes remains unclear. RESULTS: In this manuscript we present the most recent knowledge about suggested mechanisms of diabetic retinopathy, including neuroretinal apoptosis. Getting a deep insight into the role of apoptosis and degeneration of retinal neurons leading to DR will have vital consequences. CONCLUSION: The findings of this review confirm that it is very likely that in the nearest future diabetic retinopathy treatment will be based on administration of neuroprotective agents. The implementation of neuroprotective drugs may slow down retinopathy progression, making it possible to avoid the currently used therapeutic procedures, such as laser photocoagulation, intravitreous injections or posterior vitrectomy, which are not only risky for the healthy part of the retina but also relatively expensive.
format Online
Article
Text
id pubmed-5333582
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-53335822017-05-01 Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients Mrugacz, Małgorzata Bryl, Anna Bossowski, Artur Curr Neuropharmacol Article BACKGROUND: Diabetic retinopathy (DR) is an important complication of diabetes and is considered one of the main causes of blindness in moderate-income and highly-developed countries. As it is a major socioeconomic problem, defining all mechanisms that may lead to DR development is of great importance. In the 21st century diabetic lesions occurring in the retina are well known. However what kind of retinal neuronal damage occurs in the course of diabetes remains unclear. RESULTS: In this manuscript we present the most recent knowledge about suggested mechanisms of diabetic retinopathy, including neuroretinal apoptosis. Getting a deep insight into the role of apoptosis and degeneration of retinal neurons leading to DR will have vital consequences. CONCLUSION: The findings of this review confirm that it is very likely that in the nearest future diabetic retinopathy treatment will be based on administration of neuroprotective agents. The implementation of neuroprotective drugs may slow down retinopathy progression, making it possible to avoid the currently used therapeutic procedures, such as laser photocoagulation, intravitreous injections or posterior vitrectomy, which are not only risky for the healthy part of the retina but also relatively expensive. Bentham Science Publishers 2016-11 2016-11 /pmc/articles/PMC5333582/ /pubmed/27212050 http://dx.doi.org/10.2174/1570159X14666160523144245 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Mrugacz, Małgorzata
Bryl, Anna
Bossowski, Artur
Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients
title Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients
title_full Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients
title_fullStr Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients
title_full_unstemmed Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients
title_short Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients
title_sort neuroretinal apoptosis as a vascular dysfunction in diabetic patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333582/
https://www.ncbi.nlm.nih.gov/pubmed/27212050
http://dx.doi.org/10.2174/1570159X14666160523144245
work_keys_str_mv AT mrugaczmałgorzata neuroretinalapoptosisasavasculardysfunctionindiabeticpatients
AT brylanna neuroretinalapoptosisasavasculardysfunctionindiabeticpatients
AT bossowskiartur neuroretinalapoptosisasavasculardysfunctionindiabeticpatients